30

Gansu Longshenrongfa Pharmaceutical Industry Co LtdSHE 300534 Stock Report

Last reporting period 30 Sep, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.241

Micro

Exchange

XSHE - Shenzhen Stock Exchange

View Section: Company Analysis

Gansu Longshenrongfa Pharmaceutical Industry Co Rating

30

300534.SZ stock rating score is 51/100. Gansu Longshenrongfa Pharmaceutical Industry Co is aSomewhat Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

51/100

Moderate score

Rating Breakdown

  • Profitability score

    9

    /25

  • Solvency score

    14

    /25

  • Efficiency score

    13

    /25

  • Stability score

    14

    /25

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

7 %

Earnings quality

59 %

Gross Margin

61 %

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation